بدائل البحث:
largest decrease » largest decreases (توسيع البحث), marked decrease (توسيع البحث)
larger decrease » marked decrease (توسيع البحث)
ct largest » _ largest (توسيع البحث)
ad cases » all cases (توسيع البحث), 19 cases (توسيع البحث), _ cases (توسيع البحث)
26 cases » 16 cases (توسيع البحث), 24 cases (توسيع البحث), 19 cases (توسيع البحث)
c larger » _ larger (توسيع البحث), c large (توسيع البحث), _ large (توسيع البحث)
largest decrease » largest decreases (توسيع البحث), marked decrease (توسيع البحث)
larger decrease » marked decrease (توسيع البحث)
ct largest » _ largest (توسيع البحث)
ad cases » all cases (توسيع البحث), 19 cases (توسيع البحث), _ cases (توسيع البحث)
26 cases » 16 cases (توسيع البحث), 24 cases (توسيع البحث), 19 cases (توسيع البحث)
c larger » _ larger (توسيع البحث), c large (توسيع البحث), _ large (توسيع البحث)
-
161
Image2_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.JPEG
منشور في 2022"…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …"
-
162
Table10_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.XLSX
منشور في 2022"…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …"
-
163
Table7_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.XLSX
منشور في 2022"…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …"
-
164
Table4_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.XLSX
منشور في 2022"…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …"
-
165
Table9_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.XLSX
منشور في 2022"…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …"
-
166
Table12_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.XLSX
منشور في 2022"…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …"
-
167
Table2_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.XLSX
منشور في 2022"…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …"
-
168
Image1_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.JPEG
منشور في 2022"…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …"
-
169
Table3_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.XLSX
منشور في 2022"…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …"
-
170
Table6_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.XLSX
منشور في 2022"…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …"
-
171
Table11_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.XLSX
منشور في 2022"…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …"
-
172
Table8_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.XLSX
منشور في 2022"…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …"
-
173
Table1_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.XLS
منشور في 2022"…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …"
-
174
-
175
-
176
-
177
RHD case detection among the first degree relatives according to proband status in 39 households.
منشور في 2021الموضوعات: -
178
-
179
-
180